Status:
ACTIVE_NOT_RECRUITING
The Precision CAD Trial
Lead Sponsor:
Emory University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
21-90 years
Phase:
NA
Brief Summary
People with Coronary Artery Disease (CAD) have narrow or blocked arteries that supply blood to the heart. Reduced blood flow to the heart muscle from CAD can cause chest pain or aching, especially wit...
Detailed Description
People with Coronary Artery Disease (CAD) have narrow or blocked arteries that supply blood to the heart. Reduced blood flow to the heart muscle from CAD can cause chest pain or aching, especially wit...
Eligibility Criteria
Inclusion
- Individuals aged 21-90 years with stable CAD.
- Patients with any amount of atherosclerosis via coronary angiogram or coronary computed tomography angiography (CCTA).
- Patients undergoing revascularization therapy or recent acute coronary syndrome (ACS) will be eligible for recruitment and will be recruited at least 4 weeks after admission for an ACS or percutaneous intervention and 3 months after coronary bypass graft surgery.
- Patients with CAC levels ≥ 400
Exclusion
- Planned revascularization,
- New York Heart Association class III or IV heart failure symptoms,
- LVEF \<40%,
- eGFR\<45,
- Pregnancy, congenital heart disease, severe symptomatic valvular heart disease, active malignancy and cardiac transplant.
Key Trial Info
Start Date :
October 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2028
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT04755413
Start Date
October 19 2022
End Date
December 1 2028
Last Update
November 21 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Johns Creek Hospiatl
Atlanta, Georgia, United States, 30097
2
Emory University Hospital Midtown
Atlanta, Georgia, United States, 30308
3
Emory University Hospital
Atlanta, Georgia, United States, 30322
4
The Emory Clinic
Atlanta, Georgia, United States, 30324